Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $164,570 (100.0% shares, 0.0% debt)

Holdings (25)

BIOSPECIFICS TECHNOLOGIES 12.6%
Value ($000) $20,695 Shares 461,315 Est. Cost $45.13 Unrealized
CTI BIOPHARMA CORP 12.3%
Value ($000) $20,166 Shares 4,049,298 Est. Cost $3.59 Unrealized
APOLLO ENDOSURGERY INC 10.9%
Value ($000) $17,994 Shares 2,577,996 Est. Cost $4.75 Unrealized
AMARIN CORP PLC -ADR 10.6%
Value ($000) $17,521 Shares 5,670,205 Est. Cost $3.01 Unrealized
VNDA VANDA PHARMACEUTICALS INC 6.9%
Value ($000) $11,430 Shares 600,000 Est. Cost $14.90 Unrealized +12.2%
VIVEVE MEDICAL INC 6.4%
Value ($000) $10,471 Shares 3,849,711 Est. Cost $6.92 Unrealized
CPIX CUMBERLAND PHARMACEUTICALS 4.5%
Value ($000) $7,376 Shares 1,203,339 Est. Cost $5.83 Unrealized +7.4%
CORREVIO PHARMA CORP 4.4%
Value ($000) $7,295 Shares 1,930,022 Est. Cost $3.78 Unrealized
ALIMERA SCIENCES INC 4.2%
Value ($000) $6,830 Shares 6,981,184 Est. Cost $1.18 Unrealized
NOVELION THERAPEUTICS INC 4.0%
Value ($000) $6,598 Shares 1,792,911 Est. Cost $8.14 Unrealized
HTG MOLECULAR DIAGNOSTICS 3.3%
Value ($000) $5,506 Shares 1,689,064 Est. Cost $3.26 Unrealized
OPHTHOTECH CORP 3.2%
Value ($000) $5,220 Shares 1,912,018 Est. Cost $4.11 Unrealized
BIODELIVERY SCIENCES INTL 2.7%
Value ($000) $4,384 Shares 1,486,002 Est. Cost $2.06 Unrealized
RIGEL PHARMACEUTICALS INC 2.6%
Value ($000) $4,235 Shares 1,496,590 Est. Cost $2.83 Unrealized
ADMA ADMA BIOLOGICS INC 2.3%
Value ($000) $3,751 Shares 831,731 Est. Cost $4.98 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 1.8%
Value ($000) $2,976 Shares 194,900 Est. Cost $17.83 Unrealized 0.0%
ATEC ALPHATEC HOLDINGS INC 1.6%
Value ($000) $2,692 Shares 903,224 Est. Cost $3.55 Unrealized 0.0%
CATABASIS PHARMACEUTICALS IN 1.4%
Value ($000) $2,302 Shares 2,400,000 Est. Cost $0.96 Unrealized
CIDARA THERAPEUTICS INC 1.3%
Value ($000) $2,213 Shares 425,531 Est. Cost $5.20 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value ($000) $1,393 Shares 198,373 Est. Cost $9.81 Unrealized 0.0%
CANCER GENETICS INC 0.8%
Value ($000) $1,239 Shares 1,391,607 Est. Cost $1.85 Unrealized
GEMPHIRE THERAPEUTICS INC 0.6%
Value ($000) $1,050 Shares 103,000 Est. Cost $6.51 Unrealized
CONFORMIS INC 0.5%
Value ($000) $770 Shares 616,109 Est. Cost $1.45 Unrealized
MELINTA THERAPEUTICS INC 0.2%
Value ($000) $331 Shares 52,200 Est. Cost $6.34 Unrealized
INVIVO THERAPEUTICS HOLDINGS 0.1%
Value ($000) $132 Shares 77,900 Est. Cost $1.69 Unrealized